Tuning the surface coating of IONs toward efficient sonochemical tethering and sustained liberation of topoisomerase II poisons

References

• Bobo D, Robinson KJ, Islam J, Thurecht KJ, Corrie SR. Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date. Pharm Res. 2016;33(10):2373–2387. doi:10.1007/s11095-016-1958-527299311
   PubMed Web of Science ®Google Scholar
• Skorjanc T, Benyettou F, Olsen JC, Trabolsi A. Design of organic macrocycle-modified iron oxide nanoparticles for drug delivery. Chem Eur J. 2017;23(35):8333–8347. doi:10.1002/chem.20160524628164384
   PubMedGoogle Scholar
• Chertok B, Moffat BA, David AE, et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials. 2008;29(4):487–496. doi:10.1016/j.biomaterials.2007.08.05017964647
   PubMed Web of Science ®Google Scholar
• Zhao Z, Zhou Z, Bao J, et al. Octapod iron oxide nanoparticles as high-performance T(2) contrast agents for magnetic resonance imaging. Nat Commun. 2013;4:2266. doi:10.1038/ncomms326623903002
   PubMedGoogle Scholar
• Eguchi H, Umemura M, Kurotani R, et al. A magnetic anti-cancer compound for magnet-guided delivery and magnetic resonance imaging. Sci Rep. 2015;5:14. doi:10.1038/srep09194
   Web of Science ®Google Scholar
• Wahajuddin AS. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Int J Nanomed. 2012;7:3445–3471. doi:10.2147/IJN.S30320
   PubMed Web of Science ®Google Scholar
• Quan QM, Xie J, Gao HK, et al. HSA coated iron oxide nanoparticles as drug delivery vehicles for cancer therapy. Mol Pharm. 2011;8(5):1669–1676. doi:10.1021/mp200006f21838321
   PubMed Web of Science ®Google Scholar
• Rosenblum D, Joshi N, Tao W, Karp JM, Peer D. Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun. 2018;9:12. doi:10.1038/s41467-018-03705-y29295991
   PubMedGoogle Scholar
• Xie J, Lee S, Chen XY. Nanoparticle-based theranostic agents. Adv Drug Deliv Rev. 2010;62(11):1064–1079. doi:10.1016/j.addr.2010.07.00920691229
   PubMed Web of Science ®Google Scholar
• Ulbrich K, Hola K, Subr V, Bakandritsos A, Tucek J, Zboril R. Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies. Chem Rev. 2016;116(9):5338–5431. doi:10.1021/acs.chemrev.5b0058927109701
   PubMed Web of Science ®Google Scholar
• Yang XQ, Grailer JJ, Rowland IJ, et al. Multifunctional SPIO/DOX-loaded wormlike polymer vesicles for cancer therapy and MR imaging. Biomaterials. 2010;31(34):9065–9073. doi:10.1016/j.biomaterials.2010.08.03920828811
   PubMed Web of Science ®Google Scholar
• Unterweger H, Tietze R, Janko C, et al. Development and characterization of magnetic iron oxide nanoparticles with a cisplatin-bearing polymer coating for targeted drug delivery. Int J Nanomed. 2014;9:3659–3676. doi:10.2147/IJN.S63433
   PubMed Web of Science ®Google Scholar
• Hamley IW. Nanotechnology with soft materials. Angew Chem Int Edit. 2003;42(15):1692–1712. doi:10.1002/anie.200200546
   PubMed Web of Science ®Google Scholar
• Jain TK, Foy SP, Erokwu B, Dimitrijevic S, Flask CA, Labhasetwar V. Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice. Biomaterials. 2009;30(35):6748–6756. doi:10.1016/j.biomaterials.2009.08.04219765817
   PubMedGoogle Scholar
• Khandhar AP, Keselman P, Kemp SJ, et al. Evaluation of PEG-coated iron oxide nanoparticles as blood pool tracers for preclinical magnetic particle imaging. Nanoscale. 2017;9(3):1299–1306. doi:10.1039/c6nr08468k28059427
   PubMed Web of Science ®Google Scholar
• Kayal S, Ramanujan RV. Doxorubicin loaded PVA coated iron oxide nanoparticles for targeted drug delivery. Mater Sci Eng C-Mater Biol Appl. 2010;30(3):484–490. doi:10.1016/j.msec.2010.01.006
   Web of Science ®Google Scholar
• Mulens-Arias V, Rojas JM, Perez-Yague S, Morales MP, Barber DF. Polyethylenimine-coated SPIONs trigger macrophage activation through TLR-4 signaling and ROS production and modulate podosome dynamics. Biomaterials. 2015;52:494–506. doi:10.1016/j.biomaterials.2015.02.06825818455
   PubMed Web of Science ®Google Scholar
• Kalfalah FM, Mielke C, Christensen MO, Baechler S, Marko D, Boege F. Genotoxicity of dietary, environmental and therapeutic topoisomerase II poisons is uniformly correlated to prolongation of enzyme DNA residence. Mol Nutr Food Res. 2011;55:S127–S142. doi:10.1002/mnfr.20100050921520487
   PubMedGoogle Scholar
• Nitiss JL. Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer. 2009;9(5):338–350. doi:10.1038/nrc260719377506
   PubMed Web of Science ®Google Scholar
• Mistry AR, Felix CA, Whitmarsh RJ, et al. DNA topoisomerase II in therapy-related acute promyelocytic leukemia. N Engl J Med. 2005;352(15):1529–1538. doi:10.1056/NEJMoa04271515829534
   PubMed Web of Science ®Google Scholar
• Lyu YL, Kerrigan JE, Lin CP, et al. Topoisomerase II beta-mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane. Cancer Res. 2007;67(18):8839–8846. doi:10.1158/0008-5472.CAN-07-164917875725
   PubMed Web of Science ®Google Scholar
• Yuan Y, Wang WN, Wang BL, Zhu HY, Zhang BH, Feng MQ. Delivery of hydrophilic drug doxorubicin hydrochloride-targeted liver using apoAI as carrier. J Drug Target. 2013;21(4):367–374. doi:10.3109/1061186X.2012.75776923600747
   PubMed Web of Science ®Google Scholar
• Kizek R, Adam V, Hrabeta J, et al. Anthracyclines and ellipticines as DNA-damaging anticancer drugs: recent advances. Pharmacol Ther. 2012;133(1):26–39. doi:10.1016/j.pharmthera.2011.07.00621839775
   PubMedGoogle Scholar
• Sugimoto T, Matijevic E. Formation of uniform spherical magnetite particles by crystallization from ferrous hydroxide gels. J Colloid Interface Sci. 1980;74(1):227–243. doi:10.1016/0021-9797(80)90187-3
   Web of Science ®Google Scholar
• Kumar SA, Peter YA, Nadeau JL. Facile biosynthesis, separation and conjugation of gold nanoparticles to doxorubicin. Nanotechnology. 2008;19:49. doi:10.1088/0957-4484/19/49/495101
   Web of Science ®Google Scholar
• Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev. 2006;58(3):621–681. doi:10.1124/pr.58.3.1016968952
   PubMed Web of Science ®Google Scholar
• Sodipo BK, Aziz AA. Non-seeded synthesis and characterization of superparamagnetic iron oxide nanoparticles incorporated into silica nanoparticles via ultrasound. Ultrason Sonochem. 2015;23:354–359. doi:10.1016/j.ultsonch.2014.09.01125315418
   PubMedGoogle Scholar
• Wang Y, Tu S, Pinchuk AN, Xiong MP. Active drug encapsulation and release kinetics from hydrogel-in-liposome nanoparticles. J Colloid Interface Sci. 2013;406:247–255. doi:10.1016/j.jcis.2013.05.08123809875
   PubMedGoogle Scholar
• Martinez-Torres AC, Zarate-Trivino DG, Lorenzo-Anota HY, Avila-Avila A, Rodriguez-Abrego C, Rodriguez-Padilla C. Chitosan gold nanoparticles induce cell death in HeLa and MCF-7 cells through reactive oxygen species production. Int J Nanomed. 2018;13:3235–3250. doi:10.2147/IJN.S165289
   PubMed Web of Science ®Google Scholar
• Mai Y, Yu JJ, Bartholdy B, et al. An oxidative stress-based mechanism of doxorubicin cytotoxicity suggests new therapeutic strategies in ABC-DLBCL. Blood. 2016;128(24):2797–2807. doi:10.1182/blood-2016-03-70581427737889
   PubMedGoogle Scholar
• Savorani C, Manfe V, Biskup E, Gniadecki R. Ellipticine induces apoptosis in T-cell lymphoma via oxidative DNA damage. Leuk Lymphoma. 2015;56(3):739–747. doi:10.3109/10428194.2014.92967324898668
   PubMed Web of Science ®Google Scholar
• Gonzalez-Moragas L, Yu SM, Benseny-Cases N, Sturzenbaum S, Roig A, Laromaine A. Toxicogenomics of iron oxide nanoparticles in the nematode C-elegans. Nanotoxicology. 2017;11(5):647–657. doi:10.1080/17435390.2017.134201128673184
   PubMed Web of Science ®Google Scholar
• Dobrovoiskaia MA, Clogston JD, Neun BW, Hall JB, Patri AK, McNeil SE. Method for analysis of nanoparticle hemolytic properties in vitro. Nano Lett. 2008;8(8):2180–2187. doi:10.1021/nl080561518605701
   PubMedGoogle Scholar
• Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11(9):785–797. doi:10.1038/ni.192320720586
   PubMed Web of Science ®Google Scholar
• Chen FF, Wang GK, Griffin JI, et al. Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo. Nat Nanotechnol. 2017;12(4):387–393. doi:10.1038/nnano.2016.26927992410
   PubMed Web of Science ®Google Scholar
• Nguyen VH, Lee BJ. Protein corona: a new approach for nanomedicine design. Int J Nanomed. 2017;12:3137–3151. doi:10.2147/IJN.S129300
   PubMed Web of Science ®Google Scholar
• Poller JM, Zaloga J, Schreiber E, et al. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake. Int J Nanomed. 2017;12:3207–3220. doi:10.2147/IJN.S132369
   PubMed Web of Science ®Google Scholar
• Buchtelova H, Strmiska V, Dostalova S, et al. pH-responsive hybrid organic-inorganic ruthenium nanoparticles for controlled release of doxorubicin. Part Syst Charact. 2017;34(11):9. doi:10.1002/ppsc.201700289
   Web of Science ®Google Scholar
• Lo YI. Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines. J Control Release. 2003;90(1):37–48.12767705
   PubMed Web of Science ®Google Scholar
• Shekhar A, Nomura KI, Kalia RK, Nakano A, Vashishta P. Nanobubble collapse on a silica surface in water: billion-atom reactive molecular dynamics simulations. Phys Rev Lett. 2013;111(18):5. doi:10.1103/PhysRevLett.111.184503
   Web of Science ®Google Scholar
• Kamiya H, Iijima M. Surface modification and characterization for dispersion stability of inorganic nanometer-scaled particles in liquid media. Sci Technol Adv Mater. 2010;11(4):7. doi:10.1088/1468-6996/11/4/044304
   Web of Science ®Google Scholar
• Bui TQ, Ngo HTM, Tran HT. Surface-protective assistance of ultrasound in synthesis of superparamagnetic magnetite nanoparticles and in preparation of mono-core magnetite-silica nanocomposites. J Sci. 2018;3(3):323–330.
   Web of Science ®Google Scholar
• Ramalingam V, Varunkumar K, Ravikumar V, Rajaram R. Target delivery of doxorubicin tethered with PVP stabilized gold nanoparticles for effective treatment of lung cancer. Sci Rep. 2018;8:12. doi:10.1038/s41598-018-22172-529311563
   PubMedGoogle Scholar
• Lee H, Lee K, Kim IK, Park TG. Synthesis, characterization, and in vivo diagnostic applications of hyaluronic acid immobilized gold nanoprobes. Biomaterials. 2008;29(35):4709–4718. doi:10.1016/j.biomaterials.2008.08.03818817971
   PubMedGoogle Scholar
• Rahman A, Cradock JC, Davignon JP. Dissolution and absorption of the antineoplastic agent ellipticine. J Pharm Sci. 1978;67(5):611–614. doi:10.1002/jps.2600670509641792
   PubMedGoogle Scholar
• Chen BL, Dai WB, He B, et al. Current multistage drug delivery systems based on the tumor microenvironment. Theranostics. 2017;7(3):538–558. doi:10.7150/thno.1668428255348
   PubMed Web of Science ®Google Scholar
• Recouvreux MV, Commisso C. Macropinocytosis: a metabolic adaptation to nutrient stress in cancer. Front Endocrinol. 2017;8:7. doi:10.3389/fendo.2017.00261
   PubMed Web of Science ®Google Scholar
• Schmid SL. Reciprocal regulation of signaling and endocytosis: implications for the evolving cancer cell. J Cell Biol. 2017;216(9):2623–2632. doi:10.1083/jcb.20170501728674108
   PubMedGoogle Scholar
• Yameen B, Choi WI, Vilos C, Swami A, Shi JJ, Farokhzad OC. Insight into nanoparticle cellular uptake and intracellular targeting. J Control Release. 2014;190:485–499. doi:10.1016/j.jconrel.2014.06.03824984011
   PubMed Web of Science ®Google Scholar
• Peetla C, Vijayaraghavalu S, Labhasetwar V. Biophysics of cell membrane lipids in cancer drug resistance: implications for drug transport and drug delivery with nanoparticles. Adv Drug Deliv Rev. 2013;65(13–14):1686–1698. doi:10.1016/j.addr.2013.09.00424055719
   PubMed Web of Science ®Google Scholar
• Sok M, Sentjurc M, Schara M, Stare J, Rott T. Cell membrane fluidity and prognosis of lung cancer. Ann Thorac Surg. 2002;73(5):1567–1571. doi:10.1016/s0003-4975(02)03458-612022551
   PubMed Web of Science ®Google Scholar
• Geng QQ, Dong DF, Chen NZ, et al. Induction of p53 expression and apoptosis by a recombinant dual-target MDM2/MDMX inhibitory protein in wild-type p53 breast cancer cells. Int J Oncol. 2013;43(6):1935–1942. doi:10.3892/ijo.2013.213824126697
   PubMedGoogle Scholar
• Zhang XY, Zeng GJ, Tian JW, et al. PEGylation of carbon nanotubes via mussel inspired chemistry: preparation, characterization and biocompatibility evaluation. Appl Surf Sci. 2015;351:425–432. doi:10.1016/j.apsusc.2015.05.160
   Web of Science ®Google Scholar